LABOCANNA S.A. ZY-10 Total Liabilities
LABOCANNA S.A. ZY-10 total liabilities. Based on the latest financial reports, LABOCANNA S.A. ZY-10 (9Y2) has total liabilities worth €6.70 Million EUR (≈ $7.83 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 9Y2 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of LABOCANNA S.A. ZY-10 (2022–2025)
Total liabilities of LABOCANNA S.A. ZY-10 from 2022 to 2025. This chart illustrates how LABOCANNA S.A. ZY-10's total liabilities have evolved over time, based on quarterly financial data.
LABOCANNA S.A. ZY-10 Competitors by Total Liabilities
The table below lists competitors of LABOCANNA S.A. ZY-10 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft AG
XETRA:EFF
|
Germany | €18.41 Million |
|
Hotel Fast SSE AB (publ)
ST:MAXENT-B
|
USA | Skr936.44 Million |
|
Veganz Group AG
F:VEZ
|
Germany | €20.64 Million |
|
Tessin Nordic Holding AB
ST:TESSIN
|
Sweden | Skr221.96 Million |
|
Shree Ram Proteins Limited
NSE:SRPL
|
India | Rs541.28 Million |
|
Europejskie Centrum Odszkodowań SA
WAR:EUC
|
Poland | zł94.12 Million |
|
Eco Animal Health Group Plc
LSE:EAH
|
UK | GBX21.57 Million |
|
Maven Income And Growth Vct 3 Plc
LSE:MIG3
|
UK | GBX471.00K |
Liability Composition Analysis (2022–2025)
This chart breaks down LABOCANNA S.A. ZY-10's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see LABOCANNA S.A. ZY-10 (9Y2) total assets.
Liquidity & Leverage Metrics
LABOCANNA S.A. ZY-10 Total Liabilities Ratios Explained
LABOCANNA S.A. ZY-10 total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.39 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.39 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.70 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how LABOCANNA S.A. ZY-10's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for LABOCANNA S.A. ZY-10 (2022–2025)
The table below shows the annual total liabilities of LABOCANNA S.A. ZY-10 from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €7.75 Million ≈ $9.06 Million |
+329.32% |
| 2024-12-31 | €1.80 Million ≈ $2.11 Million |
+229.21% |
| 2023-12-31 | €548.01K ≈ $640.69K |
-53.81% |
| 2022-12-31 | €1.19 Million ≈ $1.39 Million |
-- |
About LABOCANNA S.A. ZY-10
Labocanna S.A. engages in the cultivation, production, and distribution of hemp product. The company also offers food and medical hemp-derived products, as well as CBD oil under the Labocanna brand name. It is also involved in commercial real estate management activities. Its products are used in cosmetics, plastics, and textiles. The company was formerly known as Foxbuy.com S.A. and changed its … Read more